GUTS Jay David Caplan sells $42K worth of shares
Mar 27, 2025, 10:35 AM
-0.79%
What does GUTS do
Fractyl Health, headquartered in Burlington, Massachusetts, focuses on treating metabolic diseases like type 2 diabetes and obesity with its Revita DMR System and Rejuva gene therapy. The company went public on February 2, 2024, and employs 102 full-time staff.
Jay David Caplan sold 21,472 shares of GUTS on 30 January at $1.95 per share, worth a total of $42K. They now own 153,544 GUTS shares, or a 12% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.